Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection von Kozal, Michael, Aberg, Judith, Pialoux, Gilles, Cahn, Pedro, Thompson, Melanie, Molina, Jean-Michel, Grinsztejn, Beatriz, Diaz, Ricardo, Castagna, Antonella, Kumar, Princy, Latiff, Gulam, DeJesus, Edwin, Gummel, Mark, Gartland, Margaret, Pierce, Amy, Ackerman, Peter, Llamoso, Cyril, Lataillade, Max

Volltext

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1 von Ackerman, Peter, Thompson, Melanie, Molina, Jean-Michel, Aberg, Judith, Cassetti, Isabel, Kozal, Michael, Castagna, Antonella, Martins, Marcelo, Ramgopal, Moti, Sprinz, Eduardo, Treviño-Pérez, Sandra, Streinu-Cercel, Adrian, Latiff, Gulam H., Pialoux, Gilles, Kumar, Princy N., Wang, Marcia, Chabria, Shiven, Pierce, Amy, Llamoso, Cyril, Lataillade, Max

Volltext

Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study von Lataillade, Max, Lalezari, Jacob P, Kozal, Michael, Aberg, Judith A, Pialoux, Gilles, Cahn, Pedro, Thompson, Melanie, Molina, Jean-Michel, Moreno, Santiago, Grinsztejn, Beatriz, Diaz, Ricardo S, Castagna, Antonella, Kumar, Princy N, Latiff, Gulam H, De Jesus, Edwin, Wang, Marcia, Chabria, Shiven, Gartland, Margaret, Pierce, Amy, Ackerman, Peter, Llamoso, Cyril

Volltext

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial von Lalezari, Jacob P, Dr, Latiff, Gulam H, MD, Brinson, Cynthia, MD, Echevarría, Juan, MD, Treviño-Pérez, Sandra, MD, Bogner, Johannes R, Prof, Thompson, Melanie, MD, Fourie, Jan, MD, Sussmann Pena, Otto A, MD, Mendo Urbina, Fernando C, MD, Martins, Marcelo, MD, Diaconescu, Iulian G, MD, Stock, David A, PhD, Joshi, Samit R, DO, Hanna, George J, MD, Lataillade, Max, DO

Volltext

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial von Rubino, Domenica, Abrahamsson, Niclas, Davies, Melanie, Hesse, Dan, Greenway, Frank L, Jensen, Camilla, Lingvay, Ildiko, Mosenzon, Ofri, Rosenstock, Julio, Rubio, Miguel A, Rudofsky, Gottfried, Tadayon, Sayeh, Wadden, Thomas A, Dicker, Dror

Volltext

ANÁLISE DE SUBGRUPO DOS RESULTADOS DE EFICÁCIA E SEGURANÇA DA SEMANA 96 AVALIANDO O FOSTEMSAVIR EM PARTICIPANTES INFECTADOS POR HIV‐1 EXTENSAMENTE EXPERIMENTADOS AO TRATAMENTO NO E... von Ackerman, Peter, Aberg, Judith, Molina, Jean‐Michael, Cassetti, Isabel, Kozal, Michael, Treviño‐Pérez, Sandra, Streinu‐Cercel, Adrian, Latiff, Gulam, Zajdenverg, Roberto, Sprinz, Eduardo

Volltext

Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials von Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Gorgolas Hernandez-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masia, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.

Volltext

Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial von Dooley, Kelly E, Kaplan, Richard, Mwelase, Noluthando, Grinsztejn, Beatriz, Ticona, Eduardo, Lacerda, Marcus, Sued, Omar, Belonosova, Elena, Ait-Khaled, Mounir, Angelis, Konstantinos, Brown, Dannae, Singh, Rajendra, Talarico, Christine L, Tenorio, Allan R, Keegan, Michael R, Aboud, Michael

Volltext

365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resis... von Dyson, Alftan, Aberg, Judith A, Molina, Jean-Michel, Cassetti, Isabel, Kozal, Michael, Treviño-Pérez, Sandra, Latiff, Gulam, Lalezari, Jacob, Pialoux, Gilles, Li, Bo, Prakash, Manyu, Clark, Andrew, Tenorio, Allan R, Pierce, Amy, Lataillade, Max

Volltext

Etravirine in treatment‐experienced, HIV‐1‐infected children and adolescents: 48‐week safety, efficacy and resistance analysis of the phase II PIANO study von Tudor‐Williams, G, Cahn, P, Chokephaibulkit, K, Fourie, J, Karatzios, C, Dincq, S, Opsomer, M, Kakuda, TN, Nijs, S, Tambuyzer, L, Tomaka, FL

Volltext

HIV‐1 attachment inhibitor prodrug BMS‐663068 in antiretroviral‐experienced subjects: week 24 sub‐group analysis von Brinson, Cynthia, Lalezari, Jacob, Gulam, Latiff H, Thompson, Melanie, Echevarria, Juan, Treviño‐Pérez, Sandra, Stock, David, Samit, Joshi R, George, Hanna J, Lataillade, Max

Volltext

Safety profile of HIV‐1 attachment inhibitor prodrug BMS‐663068 in antiretroviral‐experienced subjects: week 24 analysis von Lalezari, Jacob, Latiff, Gulam H, Brinson, Cynthia, Echevarria, Juan, Treviño‐Pérez, Sandra, Bogner, Johannes R, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max

Volltext

1574Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis von Lalezari, Jacob, Latiff, Gulam H, Brinson, Cynthia, Echevarría, Juan, Treviño-Pérez, Sandra, Bogner, Johannes R, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max

Volltext

540HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis von Brinson, Cynthia, Lalezari, Jacob, Latiff, Gulam H, Thompson, Melanie, Echevarría, Juan, Treviño-Pérez, Sandra, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max

Volltext